OracleBio will be attending the 2018 Annual Meeting of the American Association for Cancer Research (AACR), which takes place from the 14th to the 18th April in Chicago.
OracleBio will be exhibiting at Booth 4040 and also presenting a poster at the conference:
‘Utilization of fluorescent multiplex IHC and digital image analysis for studying LAG-3, CD3 and CD8 positive TIL subsets in NSCLC tissue’
Poster Board Number: 22
Session Category: Immunology
Session Title: Emerging Tools and Models in Immuno-oncology Research
Session Date and Time: Wednesday Apr 18, 2018 8:00 AM – 12:00 PM
Produced in collaboration with Indivumed GmbH
OracleBio offers a range of digital pathology services to support pre-clinical and clinical oncology R&D. Using immunohistochemistry and immunoflourescence techniques, we are able to produce a variety of quantifiable results valuable to oncology research, such as immune cell number, immune cell co-localisation and spatial distribution within the tumor microenvironment. Click here to find out more information about how our services can support your oncology research.
The Annual Meeting of the AACR is in its 110th year and highlights the best cancer science and medicine from institutions from all over the world. To find out more about the AACR, please click here.
Lorcan Sherry, OracleBio’s CSO, along with our COO, John Waller, and Business Development Manager, Hannah Thomson will be at Booth 4040 throughout the meeting. If you would like to learn more about OracleBio’s services, or wish to arrange a time to speak with Lorcan, John and Hannah during the event, please contact us.
To keep up to date with all OracleBio news and events, follow us on LinkedIn by clicking the button below: